MiR-539 inhibited the malignant behaviors of breast cancer cells by targeting SP1.
Aberrant expression of microRNAs (miRNAs) was involved in the initiation and progression of human cancers. Here, we found that miR-539 was down-regulated in breast cancer tissues and cell lines. Decreased expression of miR-539 was significantly associated with the lymph node metastasis of breast cancer patients. Overexpression of miR-539 inhibited the proliferation and promoted apoptosis of breast cancer cells. Moreover, highly expressed miR-539 significantly suppressed the epithelial mesenchymal transition (EMT) and sensitized cells to cisplatin treatment. Mechanistically, miR-539 was found to target the specificity protein 1 (SP1) and down-regulated the expression of SP1 in breast cancer cells. Consistently, knockdown of miR-539 increased the expression of SP1. The expression of miR-539 and SP1 in breast cancer tissues was negatively correlated. Restoration of SP1 significantly attenuated the inhibitory effect of miR-539 on the proliferation of breast cancer cells. Taken together, our results indicated the tumor suppressive role of miR-539 in breast cancer by targeting SP1, suggesting miR-539 as a promising target for the diagnosis of breast cancer.